Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Lilly(Eli) & Co (NYSE: LLY) was $715.20 for the day, down -1.34% from the previous closing price of $724.95. In other words, the price has decreased by -$1.34 from its previous closing price. On the day, 4.24 million shares were traded.
Ratios:
Our analysis of LLY’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 210.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 181.41. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.37. In the meantime, Its Debt-to-Equity ratio is 2.44 whereas as Long-Term Debt/Eq ratio is at 2.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, HSBC Securities on April 28, 2025, Downgraded its rating to Reduce and sets its target price to $700 from $1150 previously.
On April 22, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $975.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 14 ’25 when Yuffa Ilya sold 1,250 shares for $749.24 per share. The transaction valued at 936,550 led to the insider holds 27,510 shares of the business.
Yuffa Ilya bought 2,500 shares of LLY for $1,873,100 on May 14 ’25. On Mar 13 ’25, another insider, DONALD ZAKROWSKI, who serves as the Officer of the company, bought 2,000 shares for $821.86 each.
Valuation Measures:
As of this moment, Lilly(Eli)’s Price-to-Earnings (P/E) ratio for their current fiscal year is 59.25, and their Forward P/E ratio for the next fiscal year is 24.09. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.43. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.83 while its Price-to-Book (P/B) ratio in mrq is 43.01.
Stock Price History:
Over the past 52 weeks, LLY has reached a high of $972.53, while it has fallen to a 52-week low of $677.09. The 50-Day Moving Average of the stock is -9.91%, while the 200-Day Moving Average is calculated to be -14.61%.
Shares Statistics:
A total of 948.10M shares are outstanding, with a floating share count of 849.67M. Insiders hold about 10.35% of the company’s shares, while institutions hold 78.90% stake in the company.
Earnings Estimates
Currently, 17.0 analysts are dedicated to thoroughly evaluating and rating the performance of Lilly(Eli) & Co (LLY) in the stock market.The consensus estimate for the next quarter is $6.12, with high estimates of $7.15 and low estimates of $5.8.
Analysts are recommending an EPS of between $24.14 and $20.98 for the fiscal current year, implying an average EPS of $21.8. EPS for the following year is $29.68, with 26.0 analysts recommending between $35.85 and $25.23.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 17 analysts. It ranges from a high estimate of $14.85B to a low estimate of $13.96B. As of the current estimate, Lilly(Eli) & Co’s year-ago sales were $11.3BFor the next quarter, 17 analysts are estimating revenue of $15.38B. There is a high estimate of $15.95B for the next quarter, whereas the lowest estimate is $14.8B.
A total of 28 analysts have provided revenue estimates for LLY’s current fiscal year. The highest revenue estimate was $62.38B, while the lowest revenue estimate was $58.31B, resulting in an average revenue estimate of $59.6B. In the same quarter a year ago, actual revenue was $45.04BBased on 27 analysts’ estimates, the company’s revenue will be $71.56B in the next fiscal year. The high estimate is $79.04B and the low estimate is $65.07B.
